MiniMed (MMED) Net Margin (2025 - 2026)
MiniMed (MMED) posted Net Margin of 22.1% for Q2 2026, down 57.31% on a QoQ basis from 14.05% in Q1 2026, and up 124.0% year-over-year from 9.87% in Q2 2025.
MiniMed (MMED) Net Margin (2025 - 2026) Analysis & Trends
MiniMed's Net Margin history runs 2 years deep, the most recent figure standing at 22.1% for Q2 2026.
- Quarterly Net Margin rose 124.0% year-over-year to 22.1% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 15.54% (changed N/A YoY) and the FY2026 annual result came in at 10.22%, down 289.0% from the prior year.
- Net Margin was 22.1% for Q2 2026 at MiniMed, down from 14.05% in the prior quarter.
- Across five years, Net Margin topped out at 1.02% in Q1 2025 and bottomed at 23.34% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 29.55% |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | 4.12% |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 19.57% |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | -8.93% |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 18.66% |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | -22.10% |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 13.79% |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 13.15% |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | 0.61% |
| 10 | Omnicell | 1.81 Bn | 1.57 Bn | 140.36 Mn | 3.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | -22.10% |
| Jan 23, 2026 | -14.05% |
| Apr 25, 2025 | -23.34% |
| Jan 24, 2025 | -1.02% |